Scope of Global In-Vitro Fertilization Market Strategic Research Report 2026-2031
- This report provides forecast data by value for the global IVF market, with 2025 as the base year and forecasting to 2031.
- This report provides segmentation by service/product type (Fresh IVF Cycles, Frozen IVF Cycles, Donor Cycles, Reagents & Media, Equipment) and by end-user.
- This report provides region-wise and country-level forecast data.
- This report identifies key growth drivers and inhibitors affecting the global IVF market.
- This report provides company profiles for key fertility clinic networks and technology providers.
- This report provides Porter's Five Forces, PESTLE, and SWOT analysis.
- This report identifies key future trends through 2031.
Who can use the Global In-Vitro Fertilization Market Research Report?
This research report is ideal for people who wish to understand this market. Some of the intended users are:- C-level executives and Company Directors in fertility clinic networks and reproductive health companies
- Investment managers and Healthcare private equity analysts
- Anyone operating in the IVF value chain.
Table of Contents
1. Executive Summary2. Industry Overview & Forecast
3. Market Segmentation by Type
4. Market Segmentation by Application
5. Regional Market Forecast
6. Country-Level Market Forecast
7. Growth Drivers & Inhibitors
8. Key Company Profiles
9. Competitive Landscape
10. Porter's Five Forces Analysis
11. PESTLE Analysis
12. SWOT Analysis
13. Future Trends & Outlook
Companies Mentioned
- Vitrolife AB
- CooperSurgical (Cooper Companies)
- Merck KGaA (Fertility Division)
- IGENOMIX (Eurofins Group)
- Ferring Pharmaceuticals
- Gedeon Richter
- Origio (Hamilton Thorne)
- IVI-RMA Global
- Care Fertility Group
- Monash IVF Group
- Virtus Health
- Progyny Inc.
- Genea
- Reproductive Medicine Associates (RMA)
- Fujifilm Irvine Scientific
- Cook Medical (Fertility Division)
- Nidacon International
- Gynetics Medical Products

